Seven-valent pneumococcal conjugate vaccine (PCV7) immunization for infants and catch-up immunization programs commenced in 2001 for indigenous Australian children. The incidence of invasive pneumococcal disease (IPD) in indigenous children less than 2 years of age in the Northern Territory fell from approximately 600 cases/100,000 individuals to 264 cases/100,000 individuals after the introduction of PCV7 (9) . Serotype replacement in IPD is not confirmed in this population as reported elsewhere (21) . However, replacement with nonvaccine serotypes is evident in carriage, and it is responsible for continued pneumococcal carriage rates in excess of 80% among young indigenous children (15) . Following the introduction of PCV7, our carriage surveys of children detected a shift to a serotype hierarchy led by serotype 16F (14) and a cluster of serotype 1 carriage.
Streptococcus pneumoniae serotype 1 is an important contributor to IPD in children and adults in much of the world (6) . There can be substantial variations in the proportion of serotype 1 IPD in studies from the same population in different years and from the same country at different sites. This is due to the serotype's propensity to cause outbreaks of disease (7) . Serotype 1 is associated with complicated pneumonia, pulmonary empyema, peritonitis, and salpingitis (reviewed in reference 8) and was identified in a highly lethal pneumococcal meningitis epidemic (27) .
Serotype 1 is not commonly detected in studies of colonization, presumably due to its short duration and low density of carriage (7) . However, serotype 1 carriage can be evident during outbreaks of serotype 1 IPD. For example, a central Australian community outbreak of predominantly adult serotype 1 bacteremic pneumonia was related to nasopharyngeal (NP) colonization of 13 of 75 (17.3%) children with acute lower respiratory tract infection (4) . Furthermore, in a closed community in southern Israel, serotype 1 carriage in 26 of 650 (4%) residents across all age groups was reported during an outbreak of serotype 1 disease in adults and children (2) . We found few reports of NP serotype 1 carriage in the absence of a reported serotype 1 IPD outbreak, for example, among young children at an outpatient clinic in Mozambique (0.5% of 192 pneumococcal isolates) (24) , among outpatients presenting with acute otitis media or pneumonia in Switzerland (1.7% of 1,540 isolates) (10) , and among healthy children 7 years old or older in Turkey (4.3% of 117 isolates) (1) .
The aim of this study was to determine the molecular characteristics of serotype 1 pneumococci detected in various carriage studies and those from cases of IPD in indigenous Australians in remote communities in the Northern Territory of Australia. This included a 2002 cluster of serotype 1 carriage in children. The primary focus of this report was serotype 1 carriage in four closely situated communities in the Darwin region. Pneumococcal carriage in children and adults in these communities was studied between 1992 and 2004 ( Table 1 , studies 1 to 4). Data from a nasal pneumococcal carriage surveillance study in children 0 to 6 years of age that was undertaken in 29 communities across the Arnhem, Katherine, Darwin, and Alice regions of the Northern Territory and the Pitjantjatjara lands (included in the Alice region) in 2003 and 2005 were also included ( Table 1 , study 5).
MATERIALS AND METHODS

Ethics
Pneumococcal immunization schedule for indigenous Australians. For indigenous infants, vaccination with PCV7 is recommended at 2, 4, and 6 months of age, followed by the 23-valent pneumococcal polysaccharide vaccine (23PPV) at 18 to 24 months of age. 23PPV is also recommended for indigenous adults who are 15 to 49 years of age and medically at risk and for those who are 50 years of age and older (17) .
Carriage data. NP or nasal swabs were collected from indigenous children (less than 16 years of age) and adults enrolled in a series of longitudinal or cross-sectional studies between 1992 and 2005 (Table 1) . Pneumococcal carriage data were collected from the databases of the specific projects listed in Table 1 . All projects were undertaken by trained research staff using standardized data collection methods including WHO-recommended swab collection, storage, and microbiological analysis techniques for nasal or NP swabs (19, 23) . At least one pneumococcal colony and any that were morphologically distinct were selected from each swab for serotyping by the quellung method (Statens Serum Institut, Denmark). Serotype 1 isolates were sent to a reference laboratory (Queensland Health) for confirmation.
IPD data. IPD cases reported from Northern Territory hospital patients identifying the Northern Territory as their place of residence, and where the serotype was known, were included. A case of IPD was defined as the isolation or detection of S. pneumoniae from a blood, cerebrospinal fluid, or other sterile site sample by nucleic acid testing. Enhanced surveillance and notification of IPD began in 1994. Collection and analysis of IPD data and isolates have been described previously (20, 26) .
Molecular typing. All serotype 1 isolates were analyzed by BOX typing (25) . Selected isolates of each BOX type and region were further analyzed by multilocus sequence typing (MLST) (3) using primers found in the MLST database (http://spneumoniae.mlst.net/misc/info.asp#experimental), with the exception of the spi forward primer (spiF3, 5Ј-CAGATTTTGCAAGCCTATGG), the recP reverse primer (recPR2, 5Ј-GCCGTGTACAGCATTAGTTC), and the ddl forward primer (ddlF2, 5Ј-GATGGCTCTGTTCAAGGATT).
RESULTS
Serotype 1 carriage in the four Darwin region communities.
The earliest study, conducted from 1992 to 1993 (study 1 [11] ), identified three infant pneumococcal serotype 1 carriers and, furthermore, two carriers from among the siblings of study participants (66 NP swabs were collected from siblings of 31 (Fig. 2) . These cases were not from communities that had concomitant carriage studies. The median age of patients with serotype 1 IPD was 26.5 years, and 86% of cases were indigenous Australians. The serotype 1 IPD cases were associated with 20 cases of (blood culture-positive) pneumonia, 3 cases of meningitis, and 1 case each of bacteremia, peritonitis, and septic arthritis. There was a single death of an adult patient with bacteremia.
Duration and density of serotype 1 carriage. In longitudinal studies with 2 to 4 weekly samplings, serotype 1 strains were generally detected at single examinations. Only one child was found to carry a serotype 1 pneumococcus strain at two consecutive examinations. This was followed by detection of serotype 1 in bilateral ear discharge samples 1 month later. Serotype 1 isolates were detected at low and very high densities, as determined by a semiquantitative culture measure (22) . Simultaneous colonization with other pneumococcal serotypes was detected in 34% of serotype 1-positive nasal swabs, compared with 14% of swabs with multiple colonization detected for all serotypes, based on colony morphology (5). Cocolonization with nonserotypeable pneumococci was evident in another 5% of serotype 1-positive swabs.
Molecular typing. The serotype 1 isolates from NP and ear discharge swabs collected in study 1 (1992 to 1993) were designated BOX type H (Table 2) . MLST results from representative isolates corresponded to ST304 from the MLST database. Serotype 1 carriage isolates from study 4 (2002) 
DISCUSSION
Pneumococcal carriage studies in adults and children detected intermittent episodes of serotype 1 carriage and an age-specific cluster in indigenous communities in the Northern Territory of Australia. In the Darwin region, serotype 1 ST304 carriage was detected in five children in 1992 to 1993, and a decade later, we identified a cluster of serotype 1 ST227 carriage. During the following 3 years, carriage of serotype 1 ST227 was detected in children in other communities in the Darwin, Arnhem, and Katherine regions of the Northern Territory. There was no apparent increase in serotype 1 IPD cases during this time. Cases of serotype 1 ST227 IPD were not from communities with concomitant carriage studies.
The apparent restriction of serotype 1 carriage to children under 11 years of age during the carriage cluster may be related to the serotype 1 carriage detected 10 years earlier in these communities. We can speculate that serotype 1 carriage results in a protective immune response and that high-fre- 2006 (3.1%) . The authors suggested an association between carriage and the introduction of PCV7 (18) . It is unclear from our study whether the observed cluster was a replacement phenomenon related to the 2001 commencement of infant immunization and catch-up PCV7 immunization programs. Furthermore, our data cannot ascertain whether the absence of serotype 1 carriage among adults during the carriage cluster in children is related to expanded 23PPV immunization recommendations (17) .
In conclusion, we have detected serotype 1 strains circulating in carriage in indigenous children living in remote communities in the Northern Territory of Australia. The sequence types of these strains are the same as internationally disseminated IPD strains, including those found in the Northern Territory. It is generally believed that serotype 1 carriage is rarely detected because it is short-lived. Our longitudinal data support this belief, and we suggest that carriage rates are further underestimated because carriage may be "hidden" during cocolonization with other serotypes. We can further speculate from our data that serotype 1 carriage is more likely to be detected among young children who have higher pneumococcal acquisition rates and who are less likely than adults to have had previous exposure to serotype 1. 
